The Office of the Additional Director, Medical Store Depot (CGHS), is seeking information and quotations from manufacturers or authorized importers regarding the local manufacturing capacity and supply of Ustekinumab and Golimumab. Interested parties must submit their details and quotations in a sealed envelope or via email within 15 days of the circular date. The submission must include mandatory regulatory documents, including CDSCO forms, GST registration, and intellectual property details. This initiative aims to streamline the procurement of these specific medicines for CGHS beneficiaries. The process requires compliance with various legal and manufacturing status declarations.

The Office of the Additional Director, Medical Store Depot (CGHS), is seeking information and quotations from manufacturers or authorized importers regarding the local manufacturing capacity and supply of Ustekinumab and Golimumab. Interested parties must submit their details and quotations in a sealed envelope or via email within 15 days of the circular date. The submission must include mandatory regulatory documents, including CDSCO forms, GST registration, and intellectual property details. This initiative aims to streamline the procurement of these specific medicines for CGHS beneficiaries. The process requires compliance with various legal and manufacturing status declarations.